{"id":"https://openalex.org/W2470534752","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.312","title":"Assessing pretest probability in phase II trials: One step back before two steps forward.","display_name":"Assessing pretest probability in phase II trials: One step back before two steps forward.","publication_year":2014,"publication_date":"2014-01-20","ids":{"openalex":"https://openalex.org/W2470534752","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.312","mag":"2470534752"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.3_suppl.312","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.312","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.3_suppl.312","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012619170","display_name":"Daniel M. Halperin","orcid":"https://orcid.org/0000-0002-3113-930X","observed_orcids":["https://orcid.org/0000-0002-3113-930X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel M. Halperin","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047448453","display_name":"Cecile G. Dagohoy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cecile Dagohoy Dagohoy","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Jack Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Jack Lee","raw_affiliation_strings":["Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043534982","display_name":"James C. Yao","orcid":"https://orcid.org/0000-0002-1875-3962","observed_orcids":["https://orcid.org/0000-0002-1875-3962"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James C. Yao","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"3_suppl","first_page":"312","last_page":"312"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pretest-probability","display_name":"pretest probability","score":0.8769999742507935},{"id":"https://openalex.org/keywords/fda-drug-approval","display_name":"FDA drug approval","score":0.675000011920929},{"id":"https://openalex.org/keywords/gastrointestinal-cancer","display_name":"gastrointestinal cancer","score":0.6200000047683716},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/phase-ii-trial-design","display_name":"phase II trial design","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8739752769470215},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7154672741889954},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.48378750681877136},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.4828096330165863},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.4609198570251465},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4446220099925995},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43299925327301025},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34640073776245117},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.22662612795829773}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.3_suppl.312","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.312","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.3_suppl.312","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2143653828","https://openalex.org/W2111109154","https://openalex.org/W4319827421","https://openalex.org/W2053266489","https://openalex.org/W2154008785","https://openalex.org/W2907140816","https://openalex.org/W1982724131","https://openalex.org/W4407900553","https://openalex.org/W4283074563","https://openalex.org/W2143512985"],"abstract_inverted_index":{"312":[0],"Background:":[1],"With":[2,255],"frequent":[3],"phase":[4,35,54,84,184,214,224,262,268],"III":[5,269],"failures,":[6],"only":[7],"5%":[8],"of":[9,33,40,59,62,87,107,134,163,175,183,198,209,234,239,246],"new":[10,205],"oncology":[11],"drugs":[12,137,176],"entering":[13],"clinical":[14,108],"development":[15],"gain":[16],"FDA":[17,74,98,102],"approval.":[18,64,99,165,179],"We":[19,49,93,141],"hypothesize":[20],"that":[21],"pivotal":[22],"trial":[23,71,109,216,264],"failures":[24],"are":[25,151,249],"directly":[26],"related":[27],"to":[28,56,73,266],"the":[29,67,154,196,244],"poor":[30],"predictive":[31],"value":[32],"\u201cpositive\u201d":[34],"II":[36,55,85,185,215,225,231,263],"studies,":[37],"with":[38,119,136,227],"odds":[39,245],"success":[41,51,270],"varying":[42],"by":[43,172,218],"multiple":[44,147,173],"factors,":[45],"including":[46],"disease":[47,148],"site.":[48],"assessed":[50],"rates":[52,129,162,182,233],"from":[53,70,91],"allow":[57],"calculation":[58],"pretest":[60,237],"probability":[61,208,238],"eventual":[63,189,247],"Methods:":[65],"As":[66],"median":[68],"time":[69],"start":[72,110],"approval":[75,103,121,190,210,248],"is":[76],"6.3":[77],"years,":[78],"we":[79,203,259],"systematically":[80],"searched":[81],"clinicaltrials.gov":[82],"for":[83,97,191],"trials":[86,135,174,186],"GI":[88,193],"cancer":[89],"therapy":[90],"1999-2004.":[92],"reviewed":[94],"drug":[95,164],"labels":[96],"Drugs":[100,118],"without":[101],"within":[104],"12":[105],"months":[106],"were":[111,122,130],"classified":[112],"New":[113],"Drug":[114],"Application":[115],"(NDA)":[116],"eligible.":[117,127],"prior":[120,219],"considered":[123],"supplemental":[124],"NDA":[125],"(sNDA)":[126],"Success":[128],"calculated":[131],"as":[132],"proportion":[133],"eventually":[138],"approved.":[139],"Results:":[140],"identified":[142],"280":[143],"trials;":[144],"some":[145],"included":[146],"sites.":[149],"Approvals":[150],"shown":[152],"in":[153,157,167,188,201],"table.":[155],"Trials":[156],"different":[158,192],"diseases":[159,200],"had":[160],"distinct":[161,199],"sNDAsuccess":[166],"colorectal":[168],"tumors":[169],"was":[170],"driven":[171],"later":[177],"gaining":[178],"Conclusions:":[180],"Variable":[181],"resulting":[187],"cancers":[194],"reflect":[195],"landscape":[197],"which":[202],"test":[204],"therapies.":[206],"Posterior":[207],"after":[211],"a":[212,222,256],"positive":[213,223],"varies":[217],"probability.":[220],"For":[221],"study":[226],"type":[228],"I":[229],"and":[230,252],"error":[232],"0.1,":[235],"given":[236],"1%,":[240],"3%,":[241],"or":[242],"10%,":[243],"8%,":[250],"22%,":[251],"50%":[253],"respectively.":[254],"quantitative":[257],"understanding,":[258],"can":[260],"tailor":[261],"design":[265],"improve":[267],"rates.":[271],"[Table:":[272],"see":[273],"text]":[274]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2016-07-22T00:00:00"}